Loading...
By Amy Orciari Herman
Edited by David G. Fairchild, MD, MPH, and Lorenzo Di Francesco, MD, FACP, FHM
The U.S. Preventive Services Task Force again says there's not enough evidence to recommend for or against screening for high blood pressure in children and adolescents. The draft "I statement" is consistent with the group's 2013 stance on the topic.
The task force notes that it's difficult to measure the potential benefits of BP screening in youth — in particular, the potential cardiovascular risk reduction — and at the same time, screening can result in false-positives and unnecessary treatment.
Of note, other groups do recommend regular screening for high BP in children. For example, the American Academy of Pediatrics recommends annual screening beginning at age 3 years.
Comment
LINK(S):
USPSTF draft recommendation statement (Free)
USPSTF draft evidence review (Free PDF)
USPSTF grade definitions (Free)
Background: NEJM Journal Watch Pediatrics and Adolescent Medicine 2017 coverage of the importance of hypertension screening in kids (Your NEJM Journal Watch registration required)